Plain-English translation of NCT07533903 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Synchron BCI, an implanted brain-computer interface device for people with severe arm paralysis from conditions like ALS or other neurological disorders. The device is placed in a blood vessel near the brain and detects your motor-related brain signals, then translates them to control digital devices. The goal is to help restore meaningful control and independence for people who have lost the ability to move their arms.
Many people with severe neurological conditions lose the ability to move their arms, which can severely limit their independence and quality of life. Currently, there are limited options to restore this function. This trial exists to test whether the implanted brain-computer interface can safely and effectively help people regain control of digital devices and improve their daily lives.
You likely qualify if…
You likely don't qualify if…
You would undergo a surgical procedure to have the Synchron BCI device implanted in a blood vessel near your brain. After implantation, you would participate in training and testing visits at the study site and in your home to learn how to use the device to control digital functions. You would need to attend multiple clinical visits and work with the research team to optimize the device's performance, with your caregiver's support throughout the process.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Australia
Sponsor
Synchron, Inc.
Enrollment target
~10 participants
Started
May 2026
Primary completion
March 2027
Age range
21 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Senior Director, Clinical Operations
Synchron, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.